XML 44 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders’ Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 31, 2024
Feb. 28, 2023
Sep. 30, 2024
Sep. 30, 2024
Sep. 30, 2023
Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Warrants expired       122,739    
Warrants exercise price     $ 9.10 $ 9.10    
Unrecognized share-based compensation     $ 545,000 $ 545,000    
Share-based compensation expense       $ 757,000 $ 514,000  
Performance Shares [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Cash settle of grant-date fair value   $ 80,000        
Share-based compensation expense   56,000     $ 64,000  
Grant date fair value of vested shares   $ 24,000        
Modified to vest   71,000        
Shares granted       429,844    
Performance Shares [Member] | Time-Based Vesting [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Modified to vest   26,000        
2023 Plan [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Reserve shares for future issuance 650,000         650,000
2023 Plan [Member] | Maximum [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Reserve shares for future issuance 1,300,000          
2024 PSUs Program [Member] | Performance Shares [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Share-based compensation expense     $ 79,000 $ 289,000    
Shares granted 430,000